Design of a novel small peptide targeted against a tumor-specific receptor

Biochemical and Biophysical Research Communications

Volumn 275, Issue 2, 2000, Pages 631-636

  Campa, Michael J ^a   Kuan, Chien Tsun ^a   O'Connor McCourt, Maureen D ^b   Bigner, Darell D ^a   Patz Jr , Edward F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

EGFR; EGFRvIII; Hydropathic complementarity; Peptide ligands; Tumor targeting

Indexed keywords

CELL SURFACE RECEPTOR; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORODEOXYGLUCOSE F 18; LIGAND; MONOCLONAL ANTIBODY; POLYPEPTIDE; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; TUMOR CELL;

EID: 0034726734     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3347     Document Type: Article

References (20)

1. Design and recognition properties of a hydropathically complementary peptide to human interleukin 1 beta
2. Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene
3. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant
4. Purification of the extracellular domain of the epidermal growth factor receptor produced by recombinant baculovirus-infected insect cells in a 10-L reactor
5. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas
6. Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII)
7. The current status of clinical PET imaging
8. Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxyflucose PET scanning
9. The promise and pitfalls of monoclonal antibody therapeutics
10. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection
11. Improved tumor targeting with chemically cross-linked recombinant antibody fragments
12. From peptide to non peptide: The de novo design of potent, non peptidal inhibitors of platelet aggregation based on a benzodiazepinedione scaffold
13. Hydropathic anti-complementarity of amino acids based on the genetic code
14. Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA
15. Making sense from antisense: A review of experimental data and developing ideas on sense - Antisense peptide recognition
16. Recognition properties of peptides hydropathically complementary to 356-375 residues of the c-raf protein
17. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors
18. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas
19. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII